+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Long-term clinical and echocardiographic follow-up of the Freestyle stentless aortic bioprosthesis



Long-term clinical and echocardiographic follow-up of the Freestyle stentless aortic bioprosthesis



Circulation 126(11 Suppl 1): S198-S204



Stentless aortic bioprostheses were designed to provide enhanced hemodynamic performance and potentially greater longevity. The present report describes the outcomes of patients with the Freestyle stentless bioprosthesis followed for ≤18 years. Between 1993 and 2011, 430 patients underwent primary aortic valve replacement with a Freestyle bioprosthesis in the subcoronary position. Mean age was 68.2 ± 8.2 years. All of the clinical and echocardiographic data were collected prospectively. Mean overall follow-up was 9.1 ± 4.4 years and was complete in all of the patients. In-hospital mortality was 3.5% (n=15). Overall, 10- and 15-year survival were 60.7% and 35.0%, respectively. Fifty-one patients required reoperation during follow-up, including 27 for structural valve deterioration (SVD). Overall, freedom from reoperation was 91.0% and 75.0% at 10 and 15 years, whereas freedom from reoperation for SVD was 95.9% and 82.3%, respectively. At 10 and 15 years, freedom from reoperation for SVD was 94.0% and 62.6% for patients <60 years of age and 96.3% and 88.4% for patients ≥60 years of age (P=0.002). The median time to explant for SVD was 10.7 years. SVD presented mostly as acute, severe aortic insufficiency attributed to leaflet tear (77.8%). The independent risk factors for reoperation for SVD were age <60 years (P=0.001) and dyslipidemia (P=0.02). Aortic valve replacement with the Freestyle bioprosthesis in a subcoronary position provides good long-term clinical and echocardiographic outcomes for patients >60 years of age. Severe aortic insufficiency with leaflet tear is the major mode of SVD leading to reoperation in these patients.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054162363

Download citation: RISBibTeXText

PMID: 22965983

DOI: 10.1161/circulationaha.111.084806


Related references

Long-term clinical and echocardiographic follow-up of the freestyle stentless aortic bioprosthesis: the Tel Aviv Medical Center experience. Israel Medical Association Journal 15(9): 470-476, 2014

Long-term clinical outcomes 15 years after aortic valve replacement with the Freestyle stentless aortic bioprosthesis. Annals of Thoracic Surgery 97(2): 544-551, 2014

Total aortic root replacement using the freestyle aortic bioprosthesis in patients 70 years and older: Long-term clinical and echocardiographic results. 2007

Long Term Outcomes Following Freestyle Stentless Aortic Bioprosthesis Implantation: An Australian Experience. Heart, Lung and Circulation 25(1): 82-88, 2016

Echocardiographic parameters of the freestyle stentless bioprosthesis in aortic position: the European experience. Journal of the American Society of Echocardiography 12(9): 729-735, 1999

Long-term results of Freestyle stentless bioprosthesis in the aortic position: a single-center prospective cohort of 500 patients. Journal of Thoracic and Cardiovascular Surgery 148(5): 1903-1911, 2015

Outcome and follow-up of aortic valve replacement with the freestyle stentless bioprosthesis. Annals of Thoracic Surgery 71(2): 601-7; Discussion 607-8, 2001

World wide performance of the Freestyle stentless aortic bioprosthesis during a follow-up of five years. European Heart Journal 20(ABSTR SUPPL ): 538, 1999

Eleven years' experience with the Biocor stentless aortic bioprosthesis: clinical and hemodynamic follow-up with long-term relative survival rate. European Journal of Cardio-Thoracic Surgery 22(6): 912-921, 2002

Mitral valve replacement with the Quattro stentless pericardial bioprosthesis: mid-term clinical and echocardiographic follow up. Journal of Heart Valve Disease 19(3): 304-311, 2010

Freestyle stentless bioprosthesis for aortic valve therapy: 17-year clinical results. Asian Cardiovascular and Thoracic Annals 24(9): 868-874, 2017

Effect of surgeon on transprosthetic gradients after aortic valve replacement with Freestyle stentless bioprosthesis and its consequences: a follow-up study in 587 patients. Journal of Cardiothoracic Surgery 2: 40, 2007

Aortic Freestyle Stentless Bioprosthesis Leaflet Tears: Clinical Presentation and Diagnostic Accuracy of Echocardiography. Canadian Journal of Cardiology 29(10): S286-S287, 2013

Long-term results of aortic valve replacement with Edwards Prima Plus stentless bioprosthesis: eleven years' follow up. Journal of Heart Valve Disease 15(5): 691-5; Discussion 695, 2006

Aortic valve replacement using the Freedom SOLO stentless bioprosthesis: clinical and haemodynamic performance in 625 patients at medium-term follow-up. European Journal of Cardio-Thoracic Surgery 54(6): 1073-1080, 2018